Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL488436

AZD-5438
Phase I
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
Phase I
Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C

Basic Information

ChEMBL ID CHEMBL488436
Name AZD-5438
Phase Phase I
Structure Type MOL
InChI Key WJRRGYBTGDJBFX-UHFFFAOYSA-N

Known Names

Azd 5438 Azd-5438
39
Targets
59
Activities
3
Assay Types
6
PK Parameters
20
Publications
2
Known Names
1
Indications
1
Mechanisms

Molecular Properties

371.5
MW (Da)
3.38
ALogP
7
HBA
1
HBD
89.8
PSA (Ų)
0.74
QED
0
Ro5 Violations
5
Rot. Bonds

Drug Information

Molecule Type Small molecule
Chirality Achiral

Extended Properties

Molecular Formula C18H21N5O2S
MW 371.47
Aromatic Rings 3
Heavy Atoms 26
NP-Likeness -1.70

Mechanism of Action

Mechanism Action Type Target Direct Efficacy
Cyclin-dependent kinase inhibitor INHIBITOR Cyclin-dependent kinase

Indications

Neoplasms

Activity Summary

IC50 38 meas. best 8.22
Kd 19 meas. best 7.26
EC50 2 meas. best 8.3

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Spiral organ of cochlea
CHEMBL4296537
EC50 8.3 8.3 5.0 1
G1/S-specific cyclin-E1
CHEMBL3617
IC50 8.22 8.22 6.0 1
Cyclin-dependent kinase 2
CHEMBL301
IC50 8.22 8.22 6.0 5
Cyclin-dependent kinase 1
CHEMBL308
IC50 7.88 7.6725 13.3 4
G2/mitotic-specific cyclin-B1
CHEMBL2412
IC50 7.8 7.8 16.0 1
Cyclin-dependent kinase 9
CHEMBL3116
IC50 7.74 7.72 18.2 2
CDK9/cyclin T1
CHEMBL2111389
IC50 7.7 7.7 20.0 1
Cyclin-T1
CHEMBL2108
IC50 7.7 7.7 20.0 1
G1/S-specific cyclin-D3
CHEMBL2422
IC50 7.68 7.68 21.0 1
Cyclin-dependent kinase 6
CHEMBL2508
IC50 7.66 7.66 22.1 1
CDK2/Cyclin A2
CHEMBL3038469
IC50 7.35 7.35 45.0 1
Cyclin-A2
CHEMBL2582
IC50 7.35 7.35 45.0 1
Glycogen synthase kinase-3 alpha
CHEMBL2850
Kd 7.26 7.26 55.0 1
Glycogen synthase kinase-3 beta
CHEMBL262
Kd 7.21 7.21 62.0 1
Trypanosoma brucei brucei
CHEMBL612851
IC50 7.08 6.8367 84.0 3
Trypanosoma brucei
CHEMBL612849
IC50 6.68 6.63 210.0 2
AP2-associated protein kinase 1
CHEMBL3830
Kd 6.64 6.64 228.0 1
Cyclin-dependent kinase 9
CHEMBL3116
Kd 6.5 6.5 320.0 1
PC-3
CHEMBL390
IC50 6.44 6.44 360.0 1
Cyclin-dependent kinase 4
CHEMBL331
IC50 6.35 6.35 450.0 1
HCT-116
CHEMBL394
IC50 6.33 6.33 470.0 1
LoVo
CHEMBL614721
IC50 6.2 6.1333 630.0 3
Cyclin-dependent kinase 5
CHEMBL4036
Kd 6.2 6.2 627.0 1
Unchecked
CHEMBL612545
EC50 6.16 6.16 700.0 1
HeLa
CHEMBL399
IC50 6.14 6.03 730.0 2
Cyclin-dependent kinase 2
CHEMBL301
Kd 6.14 6.14 721.0 1
Interleukin-1 receptor-associated kinase 3
CHEMBL5081
Kd 6.11 6.11 771.0 1
BMP-2-inducible protein kinase
CHEMBL4522
Kd 6.08 6.08 826.0 1
Trypanosoma cruzi
CHEMBL368
IC50 5.97 5.97 1080.0 1
Leishmania infantum
CHEMBL612848
IC50 5.94 5.94 1150.0 1
Casein kinase I isoform delta
CHEMBL2828
Kd 5.93 5.93 1169.0 1
Unchecked
CHEMBL612545
Kd 5.82 5.82 1527.0 1
Mitogen-activated protein kinase 8
CHEMBL2276
Kd 5.78 5.78 1676.0 1
Mitogen-activated protein kinase 9
CHEMBL4179
Kd 5.72 5.72 1898.0 1
Casein kinase II subunit alpha'
CHEMBL4070
Kd 5.72 5.72 1882.0 1
Cyclin-dependent kinase 1
CHEMBL308
Kd 5.7 5.7 1992.0 1
Serine/threonine-protein kinase D2
CHEMBL4900
Kd 5.64 5.64 2314.0 1
Cyclin-dependent kinase 7
CHEMBL3055
Kd 5.63 5.63 2332.0 1
Voltage-gated inwardly rectifying potassium channel KCNH2
CHEMBL240
IC50 5.5 5.5 3200.0 1
Leishmania major
CHEMBL612879
IC50 5.5 5.5 3150.0 1
Casein kinase I isoform alpha
CHEMBL2793
Kd 5.49 5.49 3238.0 1
MDA-MB-231
CHEMBL400
IC50 5.14 5.14 7200.0 1
MCF7
CHEMBL387
IC50 4.97 4.97 10670.0 1

Pharmacokinetic Data

Parameter Value Units Species
AUC 6946.49 ng.hr.mL-1 Mus musculus
CL 21.8 mL.min-1.kg-1 Mus musculus
Cmax 6400.0 nM Mus musculus
F 91.0 % Mus musculus
Fu 0.087 - Rattus norvegicus
Tmax 0.33 hr Mus musculus

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Spiral organ of cochlea EC50 = 5.0 nM 8.3 Protection against cisplatin-induced toxicity in P3 mouse cochlear explants asse... 30091915
Cyclin-dependent kinase 2 IC50 = 6.0 nM 8.22 Inhibition of CDK2 18815031
G1/S-specific cyclin-E1 IC50 = 6.0 nM 8.22 Inhibition of Cyclin E/CDK2 18815031
Cyclin-dependent kinase 2 IC50 = 6.0 nM 8.22 Inhibition of CDK2 18996007
Cyclin-dependent kinase 2 IC50 = 6.0 nM 8.22 Inhibition of CDK2 (unknown origin) 32707525
Cyclin-dependent kinase 2 IC50 = 6.08 nM 8.22 Inhibition of CDK2 (unknown origin) 38488882
Cyclin-dependent kinase 2 IC50 = 6.0 nM 8.22 Inhibition of CDK2 (unknown origin) 38564299
Cyclin-dependent kinase 1 IC50 = 13.34 nM 7.88 Inhibition of CDK1 (unknown origin) 38488882
Cyclin-dependent kinase 1 IC50 = 16.0 nM 7.8 Inhibition of CDK1 (unknown origin) 32707525
Cyclin-dependent kinase 1 IC50 = 16.0 nM 7.8 Inhibition of CDK1 (unknown origin) 38564299
G2/mitotic-specific cyclin-B1 IC50 = 16.0 nM 7.8 Inhibition of Cyclin B1/CDK1 18815031
Cyclin-dependent kinase 9 IC50 = 18.25 nM 7.74 Inhibition of CDK9 (unknown origin) 38488882
Cyclin-T1 IC50 = 20.0 nM 7.7 Inhibition of Cyclin T/CDK9 18815031
Cyclin-dependent kinase 9 IC50 = 20.0 nM 7.7 Inhibition of CDK9 (unknown origin) 32707525
CDK9/cyclin T1 IC50 = 20.0 nM 7.7 Inhibition of CDK9/cyclin T1 (unknown origin) 38564299
G1/S-specific cyclin-D3 IC50 = 21.0 nM 7.68 Inhibition of Cyclin D3/CDK6 18815031
Cyclin-dependent kinase 6 IC50 = 22.05 nM 7.66 Inhibition of CDK6 (unknown origin) 38488882
Cyclin-A2 IC50 = 45.0 nM 7.35 Inhibition of Cyclin A/CDK2 18815031
CDK2/Cyclin A2 IC50 = 45.0 nM 7.35 Inhibition of CDK2/cyclin A2 (unknown origin) using histone H1 and ATP as substr... 31254921
Glycogen synthase kinase-3 alpha Kd = 55.0 nM 7.26 Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase ... 29191878

Literature References

PubMed DOI Target Context # Activities
18815031 10.1016/j.bmcl.2008.09.024 Mus musculus 6
29191878 10.1126/science.aan4368 Unchecked 4
- 10.6019/CHEMBL4495565 SARS-CoV-2 4
30091915 10.1021/acs.jmedchem.8b00669 Mus musculus 4
30647879 10.1039/C8MD00319J Trypanosoma brucei brucei 4
27519462 10.1016/j.bmc.2016.07.069 Trypanosoma brucei 3
38488882 10.1021/acs.jmedchem.3c02329 HCT-116 3
- 10.6019/CHEMBL3832761 Trypanosoma brucei 2
18815031 10.1016/j.bmcl.2008.09.024 No relevant target 2
30091915 10.1021/acs.jmedchem.8b00669 No relevant target 2
- 10.6019/CHEMBL4808148 Histone deacetylase 6 2
30091915 10.1021/acs.jmedchem.8b00669 Cyclin-dependent kinase 2 2
- 10.6019/CHEMBL4495564 Replicase polyprotein 1ab 2
18815031 10.1016/j.bmcl.2008.09.024 G1/S-specific cyclin-D3 1
18986805 10.1016/j.bmcl.2008.10.075 Voltage-gated inwardly rectifying potassium channel KCNH2 1
18986805 10.1016/j.bmcl.2008.10.075 LoVo 1
18986805 10.1016/j.bmcl.2008.10.075 Cyclin-dependent kinase 2 1
38157838 10.1016/j.bmc.2023.117561 Unchecked 1
18815031 10.1016/j.bmcl.2008.09.024 Cyclin-A2 1
18815031 10.1016/j.bmcl.2008.09.024 Serum 1

Data from ChEMBL 36 via Core Engine